BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10822046)

  • 1. Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor.
    Wood M; Chaubey M; Atkinson P; Thomas DR
    Eur J Pharmacol; 2000 May; 396(1):1-8. PubMed ID: 10822046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
    Wurch T; Colpaert FC; Pauwels PJ
    Neuropharmacology; 2003 Jun; 44(7):873-81. PubMed ID: 12726819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
    Varrault A; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):367-74. PubMed ID: 1436121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S 14506: novel receptor coupling at 5-HT(1A) receptors.
    Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
    Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.
    Welsby PJ; Carr IC; Wilkinson G; Milligan G
    Br J Pharmacol; 2002 Oct; 137(3):345-52. PubMed ID: 12237254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.
    Zhang JY; Nawoschik S; Kowal D; Smith D; Spangler T; Ochalski R; Schechter L; Dunlop J
    Eur J Pharmacol; 2003 Jul; 472(1-2):33-8. PubMed ID: 12860470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
    Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
    Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector coupling.
    Walsh M; Foley JF; Kinsella BT
    Biochim Biophys Acta; 2000 Apr; 1496(2-3):164-82. PubMed ID: 10771086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.
    Fowler CJ; Ahlgren PC; Brännström G
    Br J Pharmacol; 1992 Sep; 107(1):141-5. PubMed ID: 1330157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
    Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
    Mørk A; Geisler A
    Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
    Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
    Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner.
    Malmberg A; Strange PG
    J Neurochem; 2000 Sep; 75(3):1283-93. PubMed ID: 10936212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.